Fernando Camargo recognized for pioneering scientific contributions and outstanding leadership
Fernando Camargo, Ph.D., has been named as the inaugural Regenerative Biology Endowed Chair by the Boston Children’s Hospital (BCH) Department of Pediatrics, in recognition of his pioneering scientific contributions and outstanding leadership. Camargo is a professor in the Harvard Department of Stem Cell and Regenerative Biology (HSCRB) and Harvard Medical School (HMS)...
HSCI scientists develop CRISPR-based tool for lineage tracing
A new mouse model allows scientists to track every cell in the body, from the embryo stage until adulthood. The system, published in the journal Cell, could yield a greater understanding of development, aging, and disease.
“The dream of many developmental biologists for decades is a way to reconstruct every single...
Two studies by HSCI scientists advance our understanding of cancer
Two new studies by Harvard Stem Cell Institute (HSCI) scientists give important insights into lung and liver cancers, and have potential implications for cancer treatment.
Carla Kim, Ph.D., HSCI Executive Committee member, has identified a caveat for a...
Harvard Stem Cell Institute is pleased to announce four of our Principal Faculty members have been named Howard Hughes Medical Institute (HHMI) Faculty Scholars. Fernando Camargo, Benjamin Ebert, Jayaraj Rajagopal, and John Rinn are among the...
Two HSCI Principal Faculty members, Leonard Zon, MD, and Fernando Camargo, PhD, have received awards for their outstanding contribution to the field of stem cell science from the International Society for Stem Cell Research (ISSCR),...
Mouse rhabdomyosarcoma tumors produced by activated muscle stem cells with high Yap activity (green; top panels) decrease in size when Yap activity is lowered (bottom panels, as shown by the green tumor cells starting to form muscle tissue and express normal...